🔗 Share this article

A shadow market for unapproved slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Investigational Drug Gaining Traction Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are encouraged to message these accounts directly for supplier links, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a robust trade exists on messaging services, where groups with numerous of members share “before and after” images, administration instructions and claims of rapid UK delivery. Sellers market the substance there before redirecting buyers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Experts Voice Concerns

However, physicians and chemists have warned that the sale of what is still an unapproved drug in the UK is a cause for concern and could result in users administering substances of unknown origin.

Some experts stated the demand for the experimental drug could be linked to the increasing price of licensed slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still breach medicines, marketing, and customer laws, risking penalties, prosecution or prison.

Service Response and Material Elimination

According to the social media company, the platform has taken down violative content and banned related keywords and search suggestions. The company said it was committed to maintaining the platform secure and investing in strengthening enforcement strategies.

Digital Trading Activities

Investigations also found groups with up to 9,000 participants selling retatrutide using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of members, populated with images of slimming results, positive reviews and detailed guides for mixing or administering at residence.

Within minutes of entering one community, a seller shared contact information, where the majority of transactions take place. The seller provided an guidebook and guaranteed shipping within 48 hours. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None asked about body mass, health issues or past usage.

Item Details and Costs

Within these groups, messages display black plastic packages with postal service stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use injectors typically priced at £160 for 20mg. When asked how long a pen should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for the messaging service stated it regularly moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting materials they can’t verify. Although the science behind this drug is sound, these online versions may not contain what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices increasing, individuals are using social media. But fake injections are highly risky. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she explained.

Her staff has previously encountered individuals injured by personal administration from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may subject patients to possibly significant medical dangers”.